Kornitzer Capital Management Inc. KS Lowers Stake in Option Care Health, Inc. $OPCH

Kornitzer Capital Management Inc. KS cut its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 24.2% during the first quarter, HoldingsChannel reports. The firm owned 321,856 shares of the company’s stock after selling 102,764 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Option Care Health were worth $8,664,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in OPCH. Durable Capital Partners LP boosted its stake in shares of Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after buying an additional 4,720,988 shares during the period. Southpoint Capital Advisors LP purchased a new position in shares of Option Care Health during the fourth quarter worth about $95,580,000. Sumitomo Mitsui Trust Group Inc. acquired a new position in Option Care Health in the 1st quarter valued at about $70,287,000. Norges Bank acquired a new position in Option Care Health in the 4th quarter valued at about $61,787,000. Finally, Alyeska Investment Group L.P. purchased a new stake in Option Care Health during the 4th quarter valued at approximately $38,559,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher purchased 12,500 shares of Option Care Health stock in a transaction dated Monday, May 4th. The stock was acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the acquisition, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at $14,723,319.36. This represents a 1.83% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of Option Care Health stock in a transaction dated Monday, May 4th. The stock was acquired at an average cost of $21.41 per share, with a total value of $783,820.10. Following the completion of the acquisition, the director directly owned 450,000 shares in the company, valued at approximately $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders acquired 73,264 shares of company stock valued at $1,548,316. Corporate insiders own 1.70% of the company’s stock.

Option Care Health Stock Performance

NASDAQ OPCH traded down $0.10 during trading hours on Friday, hitting $21.57. 1,803,038 shares of the stock were exchanged, compared to its average volume of 2,424,430. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The company has a market cap of $3.39 billion, a price-to-earnings ratio of 16.72, a price-to-earnings-growth ratio of 1.20 and a beta of 0.65. Option Care Health, Inc. has a 12-month low of $18.01 and a 12-month high of $36.80. The stock has a 50-day moving average of $21.03 and a 200 day moving average of $27.87.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same quarter in the previous year, the company earned $0.40 EPS. The firm’s revenue for the quarter was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, equities research analysts forecast that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on OPCH shares. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective for the company. in a research report on Friday, May 1st. The Goldman Sachs Group started coverage on Option Care Health in a report on Monday, June 8th. They issued a “neutral” rating and a $22.00 target price on the stock. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. JPMorgan Chase & Co. decreased their price target on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Finally, Morgan Stanley set a $28.00 price objective on shares of Option Care Health in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $30.54.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.